<code id='172DE5988B'></code><style id='172DE5988B'></style>
    • <acronym id='172DE5988B'></acronym>
      <center id='172DE5988B'><center id='172DE5988B'><tfoot id='172DE5988B'></tfoot></center><abbr id='172DE5988B'><dir id='172DE5988B'><tfoot id='172DE5988B'></tfoot><noframes id='172DE5988B'>

    • <optgroup id='172DE5988B'><strike id='172DE5988B'><sup id='172DE5988B'></sup></strike><code id='172DE5988B'></code></optgroup>
        1. <b id='172DE5988B'><label id='172DE5988B'><select id='172DE5988B'><dt id='172DE5988B'><span id='172DE5988B'></span></dt></select></label></b><u id='172DE5988B'></u>
          <i id='172DE5988B'><strike id='172DE5988B'><tt id='172DE5988B'><pre id='172DE5988B'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:835

          How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

          This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

          advertisement

          To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          knowledge

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Intarcia’s device
          Intarcia’s device

          Thematchstick-sized,implantabledevicefromIntarciaTherapeuticsreleasesasteady,continuous,andlow-doses

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Sickle cell gene therapy cures need to be accessible in Africa

          Redbloodcellsfromapersonwithsicklecelldisease.JonathanArmstrong/WellcomeThetreatmentofsicklecelldise